Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Table 2 Basic characteristics of cohort 2

Disease	Region	N	Age mean and range (y)	Braak (Tau)	Sex (f/m)	Figure
AD	HIP	11	72 (58–84)	V-VI	6/5	5
AD	CER	6	72 (58–84)	V-VI	3/3
Non-AD	HIP	10	86 (70–95)	I-II	6/4
Non-AD	CER	8	87 (75–95)	I-II	5/3

Hippocampus and cerebellum of AD (Braak V-VI) and non-AD (Braak I-II) donors including 6 AD and 8 non-AD cases with matched samples from the same donors. HIP: Hippocampus; CER: Cerebellum; AD: Alzheimer’s disease; y: years; f: female; m: male. For detailed description of cohort 2 samples, see Additional file 1: Table S3

ISSN: 2051-5960